Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Financials
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 3 186 2313 105 3953 161 4213 301 836--
Entreprise Value (EV)1 2 875 1572 777 5452 829 7332 921 8462 724 7392 550 509
P/E ratio 14,4x16,0x26,2x17,9x13,9x11,9x
Yield 2,29%-2,47%2,81%3,13%3,53%
Capitalization / Revenue 2,44x2,39x2,53x2,49x2,34x2,19x
EV / Revenue 2,20x2,14x2,26x2,20x1,93x1,69x
EV / EBITDA 9,35x8,95x13,6x9,15x7,35x6,10x
Price to Book 2,49x2,41x2,28x2,25x2,08x1,91x
Nbr of stocks (in thousands) 1 921 1521 858 4051 857 4741 852 882--
Reference price (JPY) 1 6591 6711 7021 7821 7821 782
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 1 306 3481 300 8431 249 5281 327 3041 409 1961 505 761
EBITDA1 307 370310 387208 703319 477370 762418 447
Operating profit (EBIT)1 243 912243 991136 051231 862299 099345 165
Operating Margin 18,7%18,8%10,9%17,5%21,2%22,9%
Pre-Tax Profit (EBT)1 248 967245 350145 324227 930299 225344 374
Net income1 222 265195 411120 589182 999233 681268 117
Net margin 17,0%15,0%9,65%13,8%16,6%17,8%
EPS2 11510464,999,4128149
Dividend per Share2 38,0-42,050,055,762,8
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1
Net sales1 326 143325 523651 666350 900336 011327 050
EBITDA ------
Operating profit (EBIT)1 36 09054 07990 16973 66761 74467 650
Operating Margin 11,1%16,6%13,8%21,0%18,4%20,7%
Pre-Tax Profit (EBT)1 35 83053 25589 08571 70056 00074 400
Net income1 30 68740 92271 60955 90043 70060 600
Net margin 9,41%12,6%11,0%15,9%13,0%18,5%
EPS2 16,622,138,732,124,029,5
Dividend per Share ------
Announcement Date 07/30/202110/29/202110/29/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 311 074327 850331 688379 990577 097751 327
Leverage (Debt / EBITDA) -1,01x-1,06x-1,59x-1,19x-1,56x-1,80x
Free Cash Flow1 233 440-167 795275 459207 965227 281251 332
ROE (Net Profit / Equities) 17,6%15,3%9,00%13,0%16,0%17,2%
Shareholders' equity1 1 262 8691 277 1961 339 8781 403 7581 458 0651 556 710
ROA (Net Profit / Asset) 13,3%11,6%6,33%9,09%10,6%11,4%
Assets1 1 676 5161 678 8581 905 1212 013 4122 203 6042 347 954
Book Value Per Share2 667694748793858932
Cash Flow per Share2 148140104143150161
Capex1 25 19041 26731 38451 35041 21741 217
Capex / Sales 1,93%3,17%2,51%3,87%2,92%2,74%
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 3 301 836 028 722
Capitalization (USD) 29 200 665 305
Net sales (JPY) 1 249 528 000 000
Net sales (USD) 11 079 564 776
Number of employees 15 455
Sales / Employee (JPY) 80 849 434
Sales / Employee (USD) 716 892
Free-Float 98,9%
Free-Float capitalization (JPY) 3 266 936 012 742
Free-Float capitalization (USD) 28 892 017 729
Avg. Exchange 20 sessions (JPY) 7 677 378 126
Avg. Exchange 20 sessions (USD) 68 075 312
Average Daily Capital Traded 0,2%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA